SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay)

FT4 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Free thyroxine 4 (FT4) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of thyroid diseases.

IL-6 Rapid Quantitative Test (Chemiluminescence Immunoassay)

IL-6 Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Interleukin-6 (IL-6) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.

FSH Rapid Quantitative Test (Chemiluminescence Immunoassay)

FSH Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Follicle-stimulating hormone (FSH) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

tPSA Rapid Quantitative Test

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood.

HLC-100 Fully Automated HbA1c Analyzer

Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.

NGAL Rapid Quantitative Test

NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any signiﬁcant rise in serum creatinine.

The ADV Antigen Rapid Test

The ADV Antigen Rapid Test is a rapid lateral flow immunoassay for the qualitative detection of adenovirus antigen (ADV) directly from nasal/throat/nasopharyngeal swabs. It is intended to be used by professionals as a screening test and to provide preliminary test results to help diagnose acute Adenovirus infection. It provides only an initial screening test result. For professional in vitro diagnostic use only.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A